Influence of Oral Vitamin C Supplement on the Inflammation Status in Dialysis Patients

Objective A cross-over study is designed to elucidate if oral vitamin C supplementation can reduce inflammation status in maintenance dialysis patients with low vitamin C level and high CRP level.

Patients, Methods and Expected results Patients About 100 dialysis patients were recruited. Patients will be divided into two groups, and will be followed for at least 6 months.

Methods Arm 1(50cases): is given oral vitamin C 200mg per day in the first 3 months, then stop oral VitC for the next 3 months.

Arm 2(50cases): is not given vitamin C in the first 3 months, then switch to receive oral VitC 200mg per day in the next 3 months.

The demographics were recorded. Plasma Vitamin C was measured by high-performance liquid chromatography. Serum albumin, prealbumin, high-sensitivity C-reactive protein (hsCRP), ferritin, hemoglobin will be measured.

Expected results There may be positive effect of vitamin C supplementation on inflammation in maintenance dialysis patients with vitamin C deficiency and high CRP level.

Inclusion criteria

• Patients receiving maintenance hemodialysis or continuous ambulatory peritoneal dialysis, and dialysis vintage more than 3 months
• Patients aged between 18 and 80 years older
• VitC < 4ug/ml and hsCRP > 3mg/L
• for HD patients, Kt/V > 1.2 per session, at least 3 sessions per week, 4 hours per session
• for PD patients, Kt/V > 1.7 per week
• age and gender matched health control

Exclusion criteria

• Active autoimmune disease, malignancy, hepatitis
• Positive HIV serology
• Any kind of acute infection within one month, chronic infection
• Currently using steroids or immune-suppressants
• Pregnancy or breast feeding